Founded by Sierra Domb, Visual Snow Initiative Selected for WHO/Europe Public Health Innovation Platform

Founded by Sierra Domb, Visual Snow Initiative Selected for WHO/Europe Public Health Innovation Platform

Founded by Sierra Domb, the nonprofit Visual Snow Initiative (VSI) was selected for inclusion in the WHO/Europe Public Health Innovation Platform, a World Health Organization-hosted initiative that identifies and supports innovative public health solutions with the potential for system-level impact across the European Region. This recognition reflects VSI’s global impact in advancing awareness, research, education, and public health recognition of Visual Snow Syndrome (VSS). Through Sierra Domb’s vision and advocacy as Founder of the Visual Snow Initiative, the organization has helped elevate an underrecognized neurological condition into international scientific, clinical, and policy discussions. Sierra Domb has advocated for improved medical understanding, evidence-based recognition, and better outcomes for people living with Visual Snow Syndrome. VSI’s inclusion in the WHO/Europe Public Health Innovation Platform represents growing international recognition of the importance of addressing overlooked health conditions through research, education, and public health innovation. This milestone highlights the increasing global recognition of Visual Snow Syndrome and represents historic progress in advancing scientific research, clinical recognition, accessible resources, and improved care for individuals affected worldwide. (Source: Visual Snow Initiative)

The Visual Snow Initiative (VSI), a global nonprofit organization advancing research, awareness, education, advocacy, and resources for the neurological condition Visual Snow Syndrome (VSS), has been selected for inclusion in the WHO/Europe Public Health Innovation Platform.

The WHO/Europe Public Health Innovation Platform is a World Health Organization hosted initiative designed to accelerate system-level public health innovation and support the identification, assessment, prioritization, and scaling of transformative health solutions across the European Region. 

The platform brings together governments, researchers, academic institutions, and nonprofit organizations to co-develop and scale innovative approaches addressing complex and under-recognized but relevant public health challenges, such as conditions like Visual Snow Syndrome (VSS), which research estimates affects 2-3% of the population across all age groups, and is associated with high levels of marginalization, misdiagnosis, inadequate clinical recognition, and gaps in accurate information and care. Its outputs are designed to inform implementation pathways, strengthen knowledge translation, and support equitable access to effective health solutions. 

VSI’s inclusion reflects growing recognition of Visual Snow Syndrome as a legitimate neurological condition within evolving clinical and public health frameworks, and underscores the increasing need for coordinated global scientific and system-level attention to improve understanding, recognition, and care pathways. More broadly, this milestone highlights a wider shift in global health, where conditions once denied, overlooked, considered rare, or regarded as too complex to be meaningfully included are now increasingly understood and beginning to be incorporated into coordinated, cross-border public health innovation efforts.

Recognition of Visual Snow Syndrome within Evolving Science

Visual Snow Syndrome is a neurological condition characterized by continuous visual perceptual disturbances, most commonly described as persistent dynamic “visual static”, accompanied by additional visual, sensory, and non-visual symptoms. Long overlooked by the medical community, VSS has in recent years become the subject of growing peer-reviewed neurological, neuro-ophthalmological, and neuro-optometric research. It is now included within the World Health Organization’s ICD-11 classification framework, marking an important step forward in formal clinical recognition and research consolidation. 

VSI’s participation in a WHO-linked innovation platform represents a further progression, moving the condition from classification into structured system-level engagement. It also reflects growing opportunities for smaller and specialized organizations to contribute meaningfully to international health system dialogue.

Significance of VSI’s inclusion in the WHO/Europe Public Health Innovation Platform

1. Recognition of underrepresented neurological conditions

Visual Snow Syndrome has historically been underrecognized in clinical and public health systems. Its inclusion in a WHO-linked innovation platform signals that conditions existing on a spectrum of severity and affecting perception, neurological processing, and quality of life can be considered legitimate public health concerns, even when they are not widely recognized as mainstream conditions or uniformly diagnosed.

This helps shift VSS and similar conditions from the margins of clinical awareness into structured health system discussions.

2. Addressing misdiagnosis and clinical variability

Many individuals with VSS experience long delays in diagnosis or are misdiagnosed due to limited clinical familiarity. More broadly, marginalized conditions often suffer from inconsistent recognition across providers and regions.

Participation in the platform supports efforts to improve:

  • Clinical awareness
  • Diagnostic consistency
  • Interpretation of emerging research and neurological evidence

This is a key step in reducing systemic gaps between patient experience and clinical classification.

3. Reducing gaps between patient experience and medical understanding

Conditions like VSS often exist in a gap between lived experience and formal medical frameworks. Patients frequently report symptoms that are real and persistent, while clinical systems may lack standardized pathways for understanding or categorizing them.

Inclusion in a WHO-hosted innovation platform helps bring patient experience into structured dialogue with researchers, clinicians, and policy actors.

4. Strengthening pathways from research to healthcare systems

Even when research on underrecognized conditions exists, it does not always translate into clinical practice.

The platform supports:

  • Translation of emerging evidence into clinical frameworks
  • Development of clearer care pathways
  • Integration of new neurological findings into health systems

For VSS, this means research can more directly inform how care is understood and delivered.

5. Supporting equity in global health systems

Marginalized conditions often lack visibility in funding priorities, clinical guidelines, and health system planning.

By participating in a WHO-linked platform, VSI contributes to broader efforts to ensure that:

  • Less common or poorly understood conditions are not excluded from innovation processes
  • Health systems consider a wider range of neurological and sensory disorders
  • Equity is applied not only to access, but also to recognition and diagnosis

6. Building coordinated global understanding

VSS is not unique in being underrecognized. Many neurological, sensory, and chronic conditions face similar challenges globally.

This inclusion reflects a broader shift toward:

  • Coordinated international dialogue
  • Shared frameworks for evaluating emerging conditions
  • System-level collaboration rather than isolated national approaches

For patients, this increases the likelihood that understanding, recognition, and care standards will evolve more consistently across regions.

VSI’s role within the WHO/Europe Public Health Innovation Platform

Through participation in the WHO/Europe Public Health Innovation Platform, VSI will:

  • Collaborate with international public health leaders and institutions across the European Region
  • Contribute to scalable, patient-centered innovation approaches informed by lived experience and emerging clinical evidence
  • Advance awareness and clinical understanding of Visual Snow Syndrome within neurological and public health domains
  • Support integration of VSS into broader healthcare frameworks, including diagnostic and care pathways

Reflections from Sierra Domb, VSI’s Founder

“We have long advocated for greater recognition of Visual Snow Syndrome, not only within research and clinical communities but also within broader public health frameworks. As someone whose condition, symptom burden, and lived experience were denied, misdiagnosed, and inaccurately treated within medical systems, seeing this work acknowledged through inclusion in the WHO/Europe Public Health Innovation Platform is deeply meaningful.

On behalf of the VSI team, I am immensely grateful to our supporters and to the WHO for the invitation to participate in this important effort. It reflects both the progress achieved and the growing global recognition of conditions like Visual Snow Syndrome, once not understood or acknowledged. It also shows that, despite long-standing challenges, progress for such conditions can be possible.

There is increasing recognition that conditions such as Visual Snow Syndrome, while historically marginalized and often marked by symptom variability and substantial impact on quality of life, are legitimate and supported by an expanding body of scientific evidence and consistent patient-reported experience across populations and age groups. Advancing scientific understanding and medical accuracy requires sustained attention to overlooked conditions with real-world impact and increasing prevalence across all levels of healthcare.

More broadly, this reflects a shift in global health toward integrating underrepresented patient experiences into structured scientific, clinical, and policy dialogue. VSI’s inclusion represents a significant step forward for the field, and for communities affected by underrecognized conditions that have long sought clearer understanding, sustained research, accessible resources, improved care and treatment options, validation, and tangible progress.”

— Sierra Domb, Founder of the Visual Snow Initiative

The WHO/Europe Public Health Innovation Platform is grounded in principles of inclusivity, transparency, scientific rigor, and alignment with WHO frameworks.

For more information about Visual Snow Syndrome and the Visual Snow Initiative, as well as resources for patients, physicians, and researchers, please visit: visualsnowinitiative.org